secwatch.observer — SEC 8-K summary
======================================

Issuer:     Forte Biosciences, Inc. (FBRX)
CIK:        0001419041
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0001193125-23-291670
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01
LLM model:  deepseek-v4-flash:cloud@v2

Forte Biosciences appoints KPMG as new independent auditor for FY2023
---------------------------------------------------------------------

- Audit Committee approved KPMG LLP as independent registered public accounting firm for fiscal year ending Dec 31, 2023.
- Prior auditor Mayer Hoffman McCann P.C. (MHM) declined reappointment on July 31, 2023.
- No disagreements or reportable events occurred during previous fiscal years or interim period through Dec 4, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419041/000119312523291670/0001193125-23-291670-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419041/000119312523291670/d590309d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-291670

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer